News

Daré outlines expanded dual path strategy targeting $4.5B hormone therapy market while accelerating commercialization in Q4 2025
Discover Daré Bioscience's Q1 2025 dual path strategy to accelerate market access with new products, including probiotics in 2025 & hormone therapy in 2026.
The Nation Newspaper8m
Agriculture grappling with challenges despite government’s commitment
President Bola Ahmed Tinubu has reiterated his administration’s commitment to transforming agriculture into a powerful engine ...
SoundThinking, Inc. (SSTI) Q1 2025 Earnings Call Transcript
Good afternoon, and welcome to SoundThinking's First Quarter 2025 Earnings Conference Call. My name is Kevin, and I'll be your operator for today's call. Joining us are SoundThinking's CEO, Ralph ...
Marc Benioff of Salesforce: ‘You’re going to have to throw a lot against the wall before you figure out what sticks’
The billionaire co-founder of the cloud software group and owner of Time magazine says technology is ‘never good or bad. It’s what you do with it that matters’ ...